Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost?
about
Pharmacological interventions for treating dyslipidemia in patients with HIV infectionCOHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.An investigation into the influence of socioeconomic variables on gestational body mass index in pregnant women living in a peri-urban settlement, South Africa.Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa.Effects of HIV-1 gp120 and protease inhibitors on apoptotic susceptibility of CD34+ hematopoietic progenitor cells.Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings--insights from South AfricaEvaluation of a Web-based tailored intervention (TAVIE en santé) to support people living with HIV in the adoption of health promoting behaviours: an online randomized controlled trial protocol.An inhibitor of HIV-1 protease modulates constitutive eIF2α dephosphorylation to trigger a specific integrated stress response.The impact of HIV-associated lipodystrophy on healthcare utilization and costs.Improving Health and Reducing Comorbidity Associated with HIV: The Development of TAVIE en santé, a Web-Based Tailored Intervention to Support the Adoption of Health Promoting Behaviors among People Living with HIV.Nutrition and the HIV-associated lipodystrophy syndrome.Sources of racial/ethnic differences in awareness of HIV vaccine trials.
P2860
Q24236121-3EAD44C0-509E-48BC-82FC-49479EC93FF4Q33640397-0FDAB4CA-D61C-4985-B586-67E8D7045BEAQ33762086-6DD629F9-3C30-4F73-960D-3C72D08F3A46Q34486279-EB584C5D-A25C-45B5-8B5C-A5CAB4C5F6B2Q34570346-55978F80-639F-4CC3-941D-154D615F6A95Q35578696-C87A064A-A5C8-47AD-BD7C-630EED1B91F3Q35803608-00BBA1B8-3A62-4C3B-A75A-D1F6895CEAE3Q36483172-7D81FCEF-7F54-4DB2-A57D-E49665FA656EQ36782539-D9BD4ED9-F04A-452E-9C49-BC648CE32C9DQ37723669-6780AB1F-650A-494B-8B04-DAB3CEFE314EQ38061798-9A7EBEA3-EA3B-486B-AD6D-AE177B11875CQ53840337-FDE0373B-2300-4D10-AEC9-F748EC4BED13
P2860
Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antiretroviral therapy and the ...... ved survival but at what cost?
@en
type
label
Antiretroviral therapy and the ...... ved survival but at what cost?
@en
prefLabel
Antiretroviral therapy and the ...... ved survival but at what cost?
@en
P2860
P1476
Antiretroviral therapy and the ...... ved survival but at what cost?
@en
P2093
Bradbury RA
P2860
P304
P356
10.1111/J.1463-1326.2007.00760.X
P577
2007-09-06T00:00:00Z